Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat

Critical Care Medicine

Volumn 37, Issue 3, 2009, Pages 1062-1067

  Roux, Damien ^a   Gaudry, Stéphane ^a   Dreyfuss, Didier ^a,b   El Benna, Jamel ^c   De Prost, Nicolas ^c   Denamur, Erick ^a   Saumon, Georges ^c   Ricard, Jean Damien ^a,b  

^a INSERM   (France)

^b HÔPITAL LOUIS MOURIER   (France)

^c CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Bacterial infections and mycoses; Cytokines; experimental animal models; Mechanical; Nosocomial infections; Ventilation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGAL COLONIZATION; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MACROPHAGE FUNCTION; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS PNEUMONIA; QUANTITATIVE ANALYSIS; RAT; WISTAR RAT; ANIMAL; BACTERIAL PNEUMONIA; MACROPHAGE; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA;

ANIMALS; CANDIDA ALBICANS; MACROPHAGES; MALE; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; RATS; RATS, WISTAR;

EID: 62849111518     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31819629d2     Document Type: Article

References (41)

1. Bergmans DC, Bonten MJ, Gaillard CA, et al: Prevention of ventilator-associated pneumonia by oral decontamination: A prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2001; 164:382-388
2. Kollef MH, Ward S: The influence of miniBAL cultures on patient outcomes: Implications for the antibiotic management of ven- tilator-associated pneumonia. Chest 1998; 113:412-420
3. Vincent JL, Bihari DJ, Suter PM, et al: The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-644
4. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
5. Dreyfuss D, Ricard JD: Acute lung injury and bacterial infection. Clin Chest Med 2005; 26: 105-112
6. Markowicz P, Wolff M, Djedaini K, et al: Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med 2000; 161:1942-1948
7. Chastre J, Trouillet JL, Vuagnat A, et al: Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 157(4 Pt 1): 1165-1172
8. Heyland DK, Cook DJ, Marshall J, et al: The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group. Chest 1999; 115:1076-1084
9. Eggimann P, Garbino J, Pittet D: Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3:685-702
10. Azoulay E, Cohen Y, Zahar JR, et al: Practices in non-neutropenic ICU patients with Candida-positive airway specimens. Intensive Care Med 2004; 30:1384-1389
11. Adair CG, Gorman SP, Feron BM, et al: Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 1999; 25:1072-1076
12. Azoulay E, Timsit JF, Tafflet M, et al: Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest 2006; 129:110-117
13. Fagon JY, Chastre J, Hance AJ, et al: Noso-comial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94: 281-288
14. Bryan CS, Reynolds KL. Bacteremic nosoco-mial pneumonia. Analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis 1984; 129:668-671
15. Stevens RM, Teres D, Skillman JJ, et al: Pneumonia in an intensive care unit. A 30-month experience. Arch Intern Med 1974; 134:106-111
16. Jou IM, Tsai YT, Tsai CL, et al: Simplified rat intubation using a new oropharyngeal intubation wedge. J Appl Physiol 2000; 89: 1766-1770
17. Schortgen F, Bouadma L, Joly-Guillou ML, et al: Infectious and inflammatory dissemination are affected by ventilation strategy in rats with unilateral pneumonia. Intensive Care Med 2004; 30:693-701
18. Lau GW, Ran H, Kong F, et al: Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun 2004; 72: 4275-4278
19. Piroth L, Martin L, Coulon A, et al: Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics. Anti-microb Agents Chemother 1999; 43: 2484-2492
20. Yershov AL, Jordan BS, Guymon CH, et al: Relationship between the inoculum dose of Streptococcus pneumoniae and pneumonia onset in a rabbit model. Eur Respir J 2005; 25:693-700
21. O'Dowd Y, Driss F, Dang PM, et al: Antioxi-dant effect of hydroxytyrosol, a polyphenol from olive oil: Scavenging of hydrogen peroxide but not superoxide anion produced by human neutrophils. Biochem Pharmacol 2004; 68:2003-2008
22. Dang PM, Stensballe A, Boussetta T, et al: A specific p47phox-serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J Clin Invest 2006; 116:2033-2043
23. Roos D, Bot AA, van Schaik ML, et al: Interaction between human neutrophils and zy-mosan particles: The role of opsonins and divalent cations. J Immunol 1981; 126: 433-440
24. Sergeant S, McPhail LC: Opsonized zymosan stimulates the redistribution of protein ki-nase C isoforms in human neutrophils. J Immunol 1997; 159:2877-2885
25. Tapper H, Grinstein S: Fc receptor-triggered insertion of secretory granules into the plasma membrane of human neutrophils: Selective retrieval during phagocytosis. J Immunol 1997; 159:409-418
26. Blasi E, Puliti M, Pitzurra L, et al: Comparative studies on functional and secretory properties of macrophage cell lines derived from different anatomical sites. FEMS Immunol Med Microbiol 1994; 9:207-215
27. Casadevall A, Pirofski LA: Host-pathogen interactions: Basic concepts of microbial commensalism, colonization, infection, and disease. Infect Immun 2000; 68:6511-6518
28. Lee JH, Del Sorbo L, Khine AA, et al: Modulation of bacterial growth by tumor necrosis factor-alpha in vitro and in vivo. Am J Respir Crit Care Med 2003; 168:1462-1470
29. Meduri GU, Kanangat S, Stefan J, et al: Cy-tokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Re-spir Crit Care Med 1999; 160:961-967
30. Wu L, Estrada O, Zaborina O, et al: Recognition of host immune activation by Pseudomonas aeruginosa. Science 2005; 309: 774-777
31. Hogan DA, Kolter R: Pseudomonas-Candida interactions: An ecological role for virulence factors. Science 2002; 296:2229-2232
32. Vazquez-Torres A, Balish E: Macrophages in resistance to candidiasis. Microbiol Mol Biol Rev 1997; 61:170-192
33. Sadikot RT, Blackwell TS, Christman JW, et al: Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005; 171:1209-1223
34. Hilger AE, Danley DL: Alteration of polymor-phonuclear leukocyte activity by viable Candida albicans. Infect Immun 1980; 27: 714-720
35. Ballinger MN, Paine R III, Serezani CH, et al: Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aerugi-nosa. Am J Respir Cell Mol Biol 2006; 34: 766-774
36. Ojielo CI, Cooke K, Mancuso P, et al: Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation. J Immunol 2003; 171:4416-4424
37. Cheung DO, Halsey K, Speert DP: Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Infect Immun 2000; 68: 4585-4592
38. Warr GA, Jakab GJ: Alterations in lung mac-rophage antimicrobial activity associated with viral pneumonia. Infect Immun 1979; 26:492-497
39. Nseir S, Jozefowicz E, Cavestri B, et al: Impact of antifungal treatment on Candida-Pseudomonas interaction: A preliminary retrospective casecontrol study. Intensive Care Med 2007; 33: 137-142
40. Chastre J, Wolff M, Fagon JY, et al: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 2003; 290:2588-2598
41. Venkatesh MP, Pham D, Fein M, et al: Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epider-midis) and Candida albicans: Fluconazole prophylaxis enhances survival and growth. Antimicrob Agents Chemother 2007; 51: 1240-1245